photos >> 2012 >> 04 >> 23
Macclesfield  AstraZeneca Group  England  Europe  Western Europe  United States  Ardea Biosciences Inc.  Biotechnology Sector  Health Care Goods and Services  Industries  Pharmaceuticals Sector 
enlarge
AstraZeneca is seeking new opportunities amid a predicted drop in group earnings this year
Andrew Yates
A general view of Anglo-Swedish pharmaceutical company AstraZeneca, pictured in Macclesfield in northwest England, in 2008. Anglo-Swedish drugs giant on Monday said it had agreed to buy US biotechnology company Ardea Biosciences in a deal worth around $1.26 billion (956 million euros).